These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32186539)

  • 21. Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetes.
    Tavare AN; Doolittle HJ; Baburaj R
    Diabet Med; 2011 Apr; 28(4):500-3. PubMed ID: 21392071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes.
    Litonjua P; Piñero-Piloña A; Aviles-Santa L; Raskin P
    Endocr Pract; 2004; 10(2):101-6. PubMed ID: 15256325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin.
    Rendon MI; Cruz PD; Sontheimer RD; Bergstresser PR
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):461-9. PubMed ID: 2674210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acanthosis Nigricans among Native Americans: an indicator of high diabetes risk.
    Stuart CA; Smith MM; Gilkison CR; Shaheb S; Stahn RM
    Am J Public Health; 1994 Nov; 84(11):1839-42. PubMed ID: 7977931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive insulin for type 2 diabetes: the risk of causing harm.
    Nolan CJ; Ruderman NB; Prentki M
    Lancet Diabetes Endocrinol; 2013 Sep; 1(1):9-10. PubMed ID: 24622256
    [No Abstract]   [Full Text] [Related]  

  • 26. [Obese children with benign acanthosis nigricans and insulin resistance: analysis of 19 cases].
    Fu JF; Liang L; Dong GP; Jiang YJ; Zou CC
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):917-9. PubMed ID: 15733362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Injection-site skin lesions following pen-injection treatment in a 59-year-old woman with insulin-treated Type 2 diabetes mellitus.
    Winkler G; Sápi Z; Pál B; Molnár L
    Diabet Med; 1997 Dec; 14(12):1078-9. PubMed ID: 9455937
    [No Abstract]   [Full Text] [Related]  

  • 28. [Woman 19-old with hirsutism, obesity and acanthosis nigricans].
    Kępczyńska-Nyk A; Muszel M; Radziszewski M; Wocial K
    Pol Merkur Lekarski; 2016 Sep; 41(243):141-144. PubMed ID: 27755516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lichen sclerosus atrophicus at an insulin injection site: an unusual koebner phenomenon].
    Monteagudo B; Cabanillas M; Bellido D; Suárez-Amor O; Ramírez-Santos A; de la Cruz A
    Actas Dermosifiliogr; 2010 Jul; 101(6):563-5. PubMed ID: 20738983
    [No Abstract]   [Full Text] [Related]  

  • 30. [Syndrome of chronic overdose of insulin and hypoglycemic sulfanilamide drugs].
    Arzumetova DS; Saburenko MB; Shagazatova BKh; Zabikhodzhaeva GZ
    Klin Med (Mosk); 1989 Apr; 67(4):99-101. PubMed ID: 2666739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injection site lipoatrophy: a rare complication of recombinant human insulin.
    Chakraborty PP; Bhattacharjee R
    J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114
    [No Abstract]   [Full Text] [Related]  

  • 32. Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy.
    Chakraborty PP; Biswas SN
    Postgrad Med J; 2016 Jan; 92(1083):57-8. PubMed ID: 26561591
    [No Abstract]   [Full Text] [Related]  

  • 33. Acanthosis nigricans in obese patients: Presentations and implications for prevention of atherosclerotic vascular disease.
    Katz AS; Goff DC; Feldman SR
    Dermatol Online J; 2000 Sep; 6(1):1. PubMed ID: 11328611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
    Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG
    Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arguments against the use of inhaled insulin.
    Hirsch IB
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S111-4. PubMed ID: 17563299
    [No Abstract]   [Full Text] [Related]  

  • 36. Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation.
    Endo JO; Röcken C; Lamb S; Harris RM; Bowen AR
    J Am Acad Dermatol; 2010 Dec; 63(6):e113-4. PubMed ID: 21093656
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acral acanthosis nigricans associated with taking growth hormone].
    Peña Irún A
    Semergen; 2014; 40(4):e77-9. PubMed ID: 23746703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes.
    Okamura S; Hayashino Y; Kore-Eda S; Tsujii S
    Diabetes Care; 2013 Dec; 36(12):e200. PubMed ID: 24265372
    [No Abstract]   [Full Text] [Related]  

  • 39. Palifermin-induced acanthosis nigricans.
    Lane SW; Manoharan S; Mollee PN
    Intern Med J; 2007 Jun; 37(6):417-8. PubMed ID: 17535389
    [No Abstract]   [Full Text] [Related]  

  • 40. Acanthosis nigricans: a practical approach to evaluation and management.
    Higgins SP; Freemark M; Prose NS
    Dermatol Online J; 2008 Sep; 14(9):2. PubMed ID: 19061584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.